Status:
COMPLETED
Characteristics and Outcomes of a Capacity-to-Consent Assessment Service
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Cognitive Dysfunction
Eligibility:
All Genders
7+ years
Brief Summary
Background: Many medical conditions such as Alzheimer s disease limit the ability of people to think clearly. For medical scientists to best study these medical conditions, they need to enroll some p...
Detailed Description
Objective: To characterize the process and outcomes of capacity assessments of individuals who may be unable to consent to participate in research. Study population: all individuals who came to the N...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participant ages 7 to 99
- Participants must have undergone some type of capacity evaluation, consent or assent monitoring, or surrogate assessment, by the BCS, HSPU, or ACAT.
- Children (or adults) who were seen by the consultation service for the purposes of either evaluating their ability to assent or for assent monitoring
- Exclusion Criteria:
- Pregnant women or prisoners will not be included
Exclusion
Key Trial Info
Start Date :
June 26 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2021
Estimated Enrollment :
1098 Patients enrolled
Trial Details
Trial ID
NCT03258606
Start Date
June 26 2017
End Date
April 9 2021
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892